Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Regenxbio financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$9.1
2024-10-29
Market Capitalization
$447.8 M
2024-10-29
Revenue
$170.4 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 470.3M | 112.7M | 90.2M | 83.3M | 170.4M |
| Cost of goods sold | 51.8M | 54.5M | 37.2M | 33.6M | |
| Gross profit | 418.5M | 58.2M | 53.0M | 49.8M | |
| Gross profit margin, % | 89.0% | 51.6% | 58.8% | 59.7% | |
| General and administrative expense | 79.3M | 85.3M | 88.5M | 76.6M | 82.9M |
| Operating expense total | 258.5M | 321.1M | 321.2M | 283.1M | 311.2M |
| EBIT | 160.0M | (262.9M) | (268.1M) | (233.3M) | (161.2M) |
| EBIT margin, % | 34.0% | -233.2% | -297.1% | -280.0% | -94.6% |
| Investment income | 6.8M | 5.4M | 11.3M | 18.7M | 12.2M |
| Interest income | 719.0K | 342.0K | 25.0K | 12.1M | |
| Interest expense | 26.3M | 23.3M | 6.9M | ||
| Pre tax profit | 141.2M | (280.4M) | (263.6M) | (227.1M) | (193.9M) |
| Income tax expense | 13.4M | (84.0K) | (152.0K) | ||
| Net Income | 127.8M | (280.3M) | (263.5M) | (227.1M) | (193.9M) |
| EPS | 2.9 | (6.5) | (6.0) | (4.6) | (3.8) |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |